<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:adct="http://www.adctherapeutics.com/20260601"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="adct-20260601.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">adct:AwardsMateriallyModifiedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">adct:AwardsMateriallyModifiedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771910</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-7943">ADC Therapeutics SA</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-7944">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="c0" id="ixv-2711">&lt;div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Long-Term Incentives &#x2013; Equity Compensation &lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;"&gt;We maintain the 2019 Equity Incentive Plan, the Conditional Share Capital Plan and the Inducement Plan, all of which are broad-based omnibus equity compensation programs that permit the compensation committee to award various types of equity-based awards. Following a review of the benchmark data as provided by our committee&#x2019;s independent compensation adviser, the compensation committee determined the targeted number of shares to grant for our 2025 annual grant based on a review of market grant levels as measured as a percent of common shares outstanding. The targeted positioning versus market aligns our long-term incentive philosophy to norms within our industry. Grants for 2025 were issued as 100% time-vested restricted stock units. Granting in RSUs allows us to effectively manage our annual share usage while continuing to provide the necessary incentives that continue to drive shareholder alignment. We intend to annually revisit our long-term incentive program to determine which vehicles strike the right balance between shareholder alignment, engagement and performance. &lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;In February&#160;2025, we granted 650,000 RSUs to Mr.&#160;Mallik, 240,000 RSUs to Mr.&#160;Carmona and 230,000 RSUs to Dr.&#160;Zaki under the Conditional Share Capital Plan. These RSUs vest in three equal installments on the first, second and third anniversary of the grant date. &lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;"&gt;We utilize double-trigger vesting. Accordingly, unless the compensation committee determines otherwise with respect to a particular grant, to the extent a change in control of the Company occurs and the Company is not the surviving corporation (or survives only as a subsidiary of another corporation) and if the awards are assumed by, or replaced with awards with comparable terms by, the surviving corporation (or parent or subsidiary of the surviving corporation), the awards will vest or become fully exercisable, as applicable on the date that the grantee is terminated by the Company without cause or the executive terminates his or her employment with good reason if such termination is upon or within 12 months following the change in control. &lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;"&gt;The compensation committee recommends and the Board approves compensation for our NEOs. The compensation committee may make off-cycle grants for newly hired or newly promoted officers, and otherwise makes other grants only in special circumstances. We strictly refrain from retroactively granting share options, RSUs or other share-based awards and avoid aligning grant timing with the disclosure of material nonpublic information about our Company. We believe that our grant practices are appropriate and minimize questions regarding timing of grants in anticipation of material events, since grants become effective in accordance with standard grant procedures. &lt;/div&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="c0" id="ixv-7945">The compensation committee recommends and the Board approves compensation for our NEOs. The compensation committee may make off-cycle grants for newly hired or newly promoted officers, and otherwise makes other grants only in special circumstances.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="c0" id="ixv-7946">false</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="c0" id="ixv-7947">We strictly refrain from retroactively granting share options, RSUs or other share-based awards and avoid aligning grant timing with the disclosure of material nonpublic information about our Company. We believe that our grant practices are appropriate and minimize questions regarding timing of grants in anticipation of material events, since grants become effective in accordance with standard grant procedures.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c0" id="ixv-7948">true</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:PvpTableTextBlock contextRef="c0" id="ixv-4095">&lt;div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;Pay Versus Performance &lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;"&gt;The following summarizes the relationship between the total compensation paid to our CEO and other Named Executives Officers (&#x201c;NEOs&#x201d;), and our financial performance. In this discussion, our CEO is also referred to as our principal executive officer or &#x201c;PEO&#x201d;, and our NEOs other than our CEO are referred to as our &#x201c;Non-PEO NEOs&#x201d;): &lt;/div&gt;&lt;table cellpadding="0" class="BRDSX_fintab" style="border-spacing: 0; width: 468pt; margin-left: auto; margin-right: auto;"&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 6pt; width: 96pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 47.1pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 52.89pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 47.1pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 52.89pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 58.87pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 55.56pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_header"&gt;&lt;td style="width: 96pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 47.1pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Summary&lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;compensation&lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;table total for&lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;PEO&lt;sup&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 52.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Compensation &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;actually paid to &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;PEO&lt;sup&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 47.1pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;summary &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;compensation &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;table total for &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;non-PEO &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;NEOs&lt;sup&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 52.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;compensation &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;actually paid to &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;non-PEO &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;NEOs&lt;sup&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 58.87pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value of initial &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;fixed $100 &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;investment based &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;on total &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;shareholder &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;return&lt;sup&gt;(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 55.56pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Net income &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(loss) in millions &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 96pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2025&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 47.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.05pt; text-align: left;"&gt;$2,453,150&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 52.89pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"&gt;$6,047,297&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 47.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.05pt; text-align: left;"&gt;$1,381,285&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 52.89pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.94pt; text-align: left;"&gt;$2,651,931&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 58.87pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.68pt; text-align: left;"&gt;$91.93&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 55.56pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.37pt; text-align: left;"&gt;$(142.6) &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2024&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 47.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.05pt; text-align: left;"&gt;$1,837,628&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 52.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"&gt;$4,130,959&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 47.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.05pt; text-align: left;"&gt;$&lt;span style="padding-left: 7.5pt;"&gt;971,549&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 52.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.94pt; text-align: left;"&gt;$1,579,197&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 58.87pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.68pt; text-align: left;"&gt;$51.82&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 55.56pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.37pt; text-align: left;"&gt;$(157.8) &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 96pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2023&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 47.1pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.05pt; text-align: left;"&gt;$3,779,425&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 52.89pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"&gt;$2,678,585&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 47.1pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.05pt; text-align: left;"&gt;$2,831,604&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 52.89pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.94pt; text-align: left;"&gt;$2,155,670&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 58.87pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.68pt; text-align: left;"&gt;$43.23&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 55.56pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.37pt; text-align: left;"&gt;$(240.1)&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 2.75pt; width: 96pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 47.1pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 52.89pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 47.1pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 52.89pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 58.87pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 2.75pt; width: 55.56pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 3pt; margin-left: 0pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;(1)&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;See the &#x201c;Summary Compensation Table&#x201d; above for detail. The Average compensation of our Non-PEOs was also derived from the &#x201c;Summary Compensation Table&#x201d; above. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 3pt; margin-left: 0pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;(2)&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) means the total compensation as reflected in the &#x201c;Summary Compensation Table&#x201d; less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table, and adjusted for the following with respect to equity awards granted: &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus/(less) the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the vesting date value of awards which were granted and vested during the same covered fiscal year (none of the equity awards held by NEOs were granted and vested in the same year), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus/(less) the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Less, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year (none of the equity awards held by NEOs were forfeited during the year covered in the table), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the dollar value of any dividends or other earnings paid during the year on outstanding and unvested awards (no dividends or other earnings were paid by the Company during the year covered in the table), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the equity awards held by the NEOs were materially modified during the year covered in the table). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 3pt; margin-left: 20pt; text-align: left;"&gt;In making each of these adjustments, the value of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form&#160;10-K each year and the footnotes to the Summary Compensation Table. &lt;/div&gt;&lt;div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 3pt; margin-left: 20pt; text-align: left;"&gt;The tables below reflect the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEO and provide a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our PEO and Non-PEOs for the fiscal year 2025. &lt;/div&gt;&lt;table cellpadding="0" class="BRDSX_fintab" style="border-spacing: 0; width: 448pt; margin-left: 20pt;"&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 6pt; width: 396pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 38.66pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_header"&gt;&lt;td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fiscal &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year 2025 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Summary of Compensation Table Total&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.66pt;"&gt;2,453,150 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less: Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 4pt;"&gt;(1,046,500) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted In Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 6.66pt;"&gt;2,294,500 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus (Less): Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 6.66pt;"&gt;1,443,021 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus: Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year that Vested During Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 30.66pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;"&gt;Plus (Less): Change in Fair Value of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.66pt;"&gt;903,126 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Compensation Actually Paid&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.66pt;"&gt;6,047,297&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 3.25pt; width: 396pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 38.66pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" class="BRDSX_fintab" style="border-spacing: 0; width: 448pt; margin-left: 20pt;"&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 6pt; width: 396pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 36pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_header"&gt;&lt;td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fiscal &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year 2025 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Summary of Compensation Table Total&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$1,381,285 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less: Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 7.34pt;"&gt;(378,350) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted In Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;829,550 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus (Less): Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;479,344 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus: Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year that Vested During Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 28pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;"&gt;Plus (Less): Change in Fair Value of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;340,102 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Compensation Actually Paid&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$2,651,931&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 3.25pt; width: 396pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 36pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 3pt; margin-left: 0pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;(3)&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Total Shareholder Return represents the return on a fixed investment of $100 in ADC Therapeutics SA (ADCT) stock for the period beginning on the last trading day of 2022 through the end of the applicable fiscal year. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c0" decimals="0" id="ixv-7949" unitRef="usd">2453150</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c0" decimals="0" id="ixv-7950" unitRef="usd">6047297</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ixv-7951" unitRef="usd">1381285</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ixv-7952" unitRef="usd">2651931</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c0" decimals="2" id="ixv-7953" unitRef="usd">91.93</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-5" id="ixv-7954" unitRef="usd">-142600000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c1" decimals="0" id="ixv-7955" unitRef="usd">1837628</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c1" decimals="0" id="ixv-7956" unitRef="usd">4130959</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c1" decimals="0" id="ixv-7957" unitRef="usd">971549</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c1" decimals="0" id="ixv-7958" unitRef="usd">1579197</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c1" decimals="2" id="ixv-7959" unitRef="usd">51.82</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c1" decimals="-5" id="ixv-7960" unitRef="usd">-157800000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c2" decimals="0" id="ixv-7961" unitRef="usd">3779425</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c2" decimals="0" id="ixv-7962" unitRef="usd">2678585</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c2" decimals="0" id="ixv-7963" unitRef="usd">2831604</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c2" decimals="0" id="ixv-7964" unitRef="usd">2155670</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c2" decimals="2" id="ixv-7965" unitRef="usd">43.23</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="-5" id="ixv-7966" unitRef="usd">-240100000</us-gaap:NetIncomeLoss>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c0" id="ixv-4393">&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 3pt; margin-left: 0pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;(2)&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) means the total compensation as reflected in the &#x201c;Summary Compensation Table&#x201d; less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table, and adjusted for the following with respect to equity awards granted: &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus/(less) the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the vesting date value of awards which were granted and vested during the same covered fiscal year (none of the equity awards held by NEOs were granted and vested in the same year), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus/(less) the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Less, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year (none of the equity awards held by NEOs were forfeited during the year covered in the table), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the dollar value of any dividends or other earnings paid during the year on outstanding and unvested awards (no dividends or other earnings were paid by the Company during the year covered in the table), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the equity awards held by the NEOs were materially modified during the year covered in the table). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 3pt; margin-left: 20pt; text-align: left;"&gt;In making each of these adjustments, the value of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form&#160;10-K each year and the footnotes to the Summary Compensation Table. &lt;/div&gt;&lt;div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 3pt; margin-left: 20pt; text-align: left;"&gt;The tables below reflect the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEO and provide a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our PEO and Non-PEOs for the fiscal year 2025. &lt;/div&gt;&lt;table cellpadding="0" class="BRDSX_fintab" style="border-spacing: 0; width: 448pt; margin-left: 20pt;"&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 6pt; width: 396pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 36pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_header"&gt;&lt;td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fiscal &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year 2025 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Summary of Compensation Table Total&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$1,381,285 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less: Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 7.34pt;"&gt;(378,350) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted In Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;829,550 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus (Less): Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;479,344 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus: Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year that Vested During Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 28pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;"&gt;Plus (Less): Change in Fair Value of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;340,102 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Compensation Actually Paid&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 36pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$2,651,931&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 3.25pt; width: 396pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 8pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 36pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c0" id="ixv-4394">&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 3pt; margin-left: 0pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;(2)&lt;br/&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) means the total compensation as reflected in the &#x201c;Summary Compensation Table&#x201d; less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table, and adjusted for the following with respect to equity awards granted: &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus/(less) the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the vesting date value of awards which were granted and vested during the same covered fiscal year (none of the equity awards held by NEOs were granted and vested in the same year), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus/(less) the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year, &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Less, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year (none of the equity awards held by NEOs were forfeited during the year covered in the table), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus the dollar value of any dividends or other earnings paid during the year on outstanding and unvested awards (no dividends or other earnings were paid by the Company during the year covered in the table), &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; margin-top: 6pt; margin-left: 20pt;"&gt;&lt;tr&gt;&lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;"&gt;&#x2022;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align: top;"&gt;&lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;"&gt;Plus, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the equity awards held by the NEOs were materially modified during the year covered in the table). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 3pt; margin-left: 20pt; text-align: left;"&gt;In making each of these adjustments, the value of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form&#160;10-K each year and the footnotes to the Summary Compensation Table. &lt;/div&gt;&lt;div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 3pt; margin-left: 20pt; text-align: left;"&gt;The tables below reflect the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEO and provide a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our PEO and Non-PEOs for the fiscal year 2025. &lt;/div&gt;&lt;table cellpadding="0" class="BRDSX_fintab" style="border-spacing: 0; width: 448pt; margin-left: 20pt;"&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 6pt; width: 396pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 6pt; width: 38.66pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_header"&gt;&lt;td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; border-bottom: none;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fiscal &lt;br/&gt;&lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year 2025 &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Summary of Compensation Table Total&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.66pt;"&gt;2,453,150 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less: Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 4pt;"&gt;(1,046,500) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted In Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 6.66pt;"&gt;2,294,500 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus (Less): Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 6.66pt;"&gt;1,443,021 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Plus: Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year that Vested During Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 30.66pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;"&gt;Plus (Less): Change in Fair Value of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years for which Applicable Vesting Conditions were Satisfied During Fiscal Year&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.66pt;"&gt;903,126 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width: 396pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Compensation Actually Paid&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 38.66pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.66pt;"&gt;6,047,297&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr class="BRDSX_boxspacer"&gt;&lt;td style="height: 3.25pt; width: 396pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 6.67pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;td style="height: 3.25pt; width: 38.66pt; background-color: #CCEEFF;"&gt;&lt;div style="font-size: 1pt;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToCompAmt contextRef="c3" decimals="0" id="ixv-7967" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c4" decimals="0" id="ixv-7968" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c5" decimals="0" id="ixv-7969" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c6" decimals="0" id="ixv-7970" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c7" decimals="0" id="ixv-7971" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c8" decimals="0" id="ixv-7972" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c0" decimals="0" id="ixv-7973" unitRef="usd">2453150</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c9" decimals="0" id="ixv-7974" unitRef="usd">-1046500</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c10" decimals="0" id="ixv-7975" unitRef="usd">2294500</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c11" decimals="0" id="ixv-7976" unitRef="usd">1443021</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c3" decimals="0" id="ixv-7977" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c12" decimals="0" id="ixv-7978" unitRef="usd">903126</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c0" decimals="0" id="ixv-7979" unitRef="usd">6047297</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ixv-7980" unitRef="usd">1381285</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c13" decimals="0" id="ixv-7981" unitRef="usd">-378350</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c14" decimals="0" id="ixv-7982" unitRef="usd">829550</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c15" decimals="0" id="ixv-7983" unitRef="usd">479344</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c4" decimals="0" id="ixv-7984" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c16" decimals="0" id="ixv-7985" unitRef="usd">340102</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ixv-7986" unitRef="usd">2651931</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c0" id="ixv-4701">&lt;div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;"&gt;CAP versus Company Total Shareholder Return &lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;"&gt;The Company&#x2019;s Total Shareholder Return in 2025 was $91.93 based on a $100 initial fixed investment and the PEO CAP was $6.0&#160;million. The non-PEO CAP was $2.7&#160;million. The Company does not use Total Shareholder Return as a primary metric to determine compensation levels or incentive plan payout. In future years we will determine whether there are any trends in the relationship between Total Shareholder Return and CAP over time. &lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c0" id="ixv-4705">&lt;div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;CAP versus Net Income (Loss) &lt;/div&gt;&lt;div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;"&gt;As shown in the chart above, the Company&#x2019;s net loss in 2025 was $142.6&#160;million and the PEO CAP was $6.0&#160;million. The non-PEO CAP was $2.7&#160;million. The Company does not use net income/loss as a primary metric to determine compensation levels or incentive plan payout. In future years we will determine whether there are any trends in the relationship between net income/loss and CAP over time. &lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <dei:DocumentType contextRef="c0" id="hidden-fact-0">DEF 14A</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-7990">0001771910</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-7991">false</dei:AmendmentFlag>
</xbrl>
